ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway
ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathwayERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway, Published online: 21 November 2018; doi:10.1038/s41417-018-0064-8ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway
Source: Cancer Gene Therapy - Category: Cancer & Oncology Authors: Gejun Zhang Zi Yu Shui Fu Chengcheng Lv Qingzhuo Dong Cheng Fu Chuize Kong Yu Zeng Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Gene Therapy | Genetics | Kidney Cancer | Renal Cell Carcinoma